Sam Chun Dang Pharm Shares Plunge 29.79% the Day After Hitting the Upper Limit: FDA Pre-ANDA Is Not Approval
Sam Chun Dang Pharm closed at the daily upper price limit on 2026-07-20, but on the following trading day, 21, its shares finished at KRW 167,800, down 29.79% from the previous session. The rally began after the company announced that it had received a Pre-ANDA response letter from the U.S. Food and Drug Administration (FDA) concerning the development of a generic oral semaglutide product. However, a Pre-ANDA response